POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, March 9, 2009   9:30 AM - 12:00 Noon
Hynes Convention Center, Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
140
Metastatic Pancreatic Adenocarcinoma to the Ovary: A Clinicopathologic Review of Twenty Nine Cases
(929)
RA Abadeer, A Malpica - The University of Texas M.D. Anderson Cancer Center, Houston, TX
VHL Deficiency in the Female Genital Tract
(941)
CJ Bechert, SB Shively, N Yuldasheva, S Glasker, A Vortmeyer - University of Texas Medical Branch, Galveston, TX; National Institute of Neurological Disorders and Stroke, Bethesda, MD; National Cancer Institute, Bethesda, MD; Albert-Ludwigs Universitat, Freiburg, Germany; Yale University School of Medicine, New Haven, CT
Indication and Method of Frozen Section in Vaginal Radical Trachelectomy
(953)
J Chenevert, M Plante, M Roy, B Tetu, K Grondin, M-C Renaud, J Gregoire, V Dube - Centre Hospitalier Universitaire de Quebec, Quebec, QC, Canada
CpG Island Methylation within the TCF2 Promoter May Enable Epigenetic Modulation of HNF1-beta and Clear Cell Phenotype in Ovarian Clear Cell Carcinoma
(957)
J Cuff, S Huang, JP Higgins, TA Longacre, JR Pollack - Stanford University, Stanford, CA
p16 INK4a Staining Characteristics in Endometrioid Endometrial Adenocarcinoma; Information Useful When Establishing Cervical or Endometrial Origin
(960)
CM Davidson, PL Farmer, TJ Childs - Queen's University/Kingston General Hospital, Kingston, ON, Canada
A Comparison of Detection Rates between Conventional Pap Smears and the Liquid Based Pap Tests in Dysplasia Clinic
(975)
SK Galfione, D Smith, DR Mody, DM Coffey - The Methodist Hospital, Houston, TX
Can Type Specific HPV Testing Predict Persistence/Progression of Cervical Intraepithelial Neoplasia?
(977)
GE Galliano, AE Walts, R Chan, S Bose - Cedars-Sinai Medical Center, Los Angeles, CA
A Binary Grading System for Endometrial Carcinoma Compared with Existing Grading Systems
(982)
H Guan, H Arabi, K Hayek, S Bandyopadhyay, L Fathallah, JN Feng, R Ali-Fehmi - WSU, Detroit, MI; St. John Med Center, Detroit, MI
Primary Ovarian Mucinous Tumors Lack Loss of MLH-1 and MGMT and Are Characterized by KRAS Mutations and Aberrant p53 Expression When They Progress to Carcinoma
(984)
M Gupta, JL Gonzalez, JA Lefferts, A Quer, GJ Tsongalis, E Oliva - Dartmouth Hitchcock Medical Center, Lebanon, NH; Massachusetts General Hospital, Boston, MA
Endometrioid Endometrial Adenocarcinoma in Elderly Women: A Clinico-Pathologic Study
(986)
S Hafezi, S Nofech-Mozes, N Ismiil, V Dube, RS Saad, Z Ghorab, MA Khalifa - Sunnybrook Health Sciences Centre, Toronto, ON, Canada
The Significance of Adenomyosis Involved by Tumor in Otherwise Low Stage Endometrioid Adenocarcinomas
(987)
K Hanley, S Dustin, M Stoler, K Atkins - University of Virginia, Charlottesville, VA
Chromosome Y-linked Testis Specific Protein Is Chracteristically Present in Gonadoblastoma
(991)
JD Hertel, PC Huettner, LP Dehner, JD Pfeifer - Washington University School of Medicine, St Louis, MO
Invader HPV Test Reveals a Poorly-Recognized Deceiving Group of Cervical HSIL Associated with HPV Types-Not-16/18
(1004)
S Kitahara, RC Chan, WS Nichols, EG Silva - Cedars-Sinai Medical Center, Los Angeles, CA
Correlates of Papillary Infarction and Microinvasion in Ovarian Atypical Proliferative (Borderline) Serous and Seromucinous Tumors
(1013)
JA Kraus, JD Seidman - Washington Hospital Center, Washington, DC
Atypical Leiomyomas of the Uterus: A Clinicopathologic Study of 46 Cases
(1028)
A Ly, JK McKenney, TA Longacre, RL Kempson, MR Hendrickson - Stanford University Hospital, Stanford, CA
Significant Overexpression of HMGAs in Serous Ovarian Carcinoma in Association with p53
(1031)
A Mahajan, L Gellert, XJ Yang, J Wei - Feinberg School of Medicine, Northwestern University, Chicago, IL; NY University, New York, NY
Immunohistochemical Characterization of Sex Cord Stromal Tumors
(1043)
O Moshkin, S Nofech-Mozes, MA Khalifa, N Ismiil, V Dube, RS Saad, Z Ghorab - University of Toronto, Toronto, Canada; Sunnybrook Health Sciences Centre, Toronto, Canada
The Circumferential Extent of Disease Should Be Reported in Cervical Adenocarcinoma In Situ Excised by LEEP and Cone Biopsies
(1058)
A Plotkin, MA Khalifa, N Ismiil, RS Saad, V Dube, Z Ghorab, S Nofech-Mozes - University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada
A 3-Tier Grading System and Mitotic Count Predict for Outcome in Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy
(1062)
K Rahimi, C Ma, H Begley, V Nair, B Rosen, S Chin, H MacKay, PA Shaw - University Health Network, Toronto, ON, Canada
Immunohistochemical Panel To Differentiate Endometrial Papillary Serous Carcinoma from High Grade Endometrioid Carcinoma
(1068)
MA Rollins-Raval, R Byler Dann, RP Edwards, G Tseng, M Chivukula - Magee-Womens Hospital of UPMC and University of Pittsburgh, Pittsburgh, PA
Glandular Intraluminal Debris in Endometrioid Adenocarcinoma of the Endometrium Correlates with Tumor Grade and Stage: A Clinicopathologic Study of 115 Cases
(1082)
RA Simon, SL Peng, CJ Sung, WD Lawrence, C Zhang - Warren Alpert Medical School of Brown University, Providence, RI; National Cheng Kung University, Tainan, Taiwan
Diagnostic Utility of Detecting 12p Alterations by Fluorescence In Situ Hybridization in Ovarian Germ Cell Tumors
(1086)
WR Sukov, JC Cheville, AW Carlson, GL Keeney, RP Ketterling - Mayo Clinic, Rochester, MN
Combined p53 and p16 Expression Is Useful To Distinguish between Endometrial Serous and Endometrioid Carcinomas
(1093)
N Ursani, R Saleh, A Lytwyn, D Daya, C Ceballos, L Elit, M Sur, K Onuma - McMaster University, Hamilton, ON, Canada; Universitiy of British Columbia, Vancouver, BC, Canada
Prepartum Cervical Cytologic Changes Correlated with Abnormal Placental Changes and Preterm Delivery
(1109)
Z Zuo, S Goel, JE Carter - University of South Alabama, Mobile, AL